Prevention and control of cardiovascular disease in the rapidly changing economy of China

Circulation

Volumn 133, Issue 24, 2016, Pages 2545-2560

  Wu, Yangfeng ^a   Benjamin, Emelia J ^b   MacMahon, Stephen ^c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BOSTON UNIVERSITY   (United States)

^c GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

Author keywords

cardiovascular diseases; China; prevention control; risk factors; socioeconomic factors

Indexed keywords

ALCOHOL; SODIUM CHLORIDE;

ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINA; DEMOGRAPHY; DIABETES MELLITUS; DIET; DYSLIPIDEMIA; ECONOMIC ASPECT; ENVIRONMENTAL CHANGE; GOVERNMENT; HEALTH CARE SYSTEM; HEALTH STATUS; HOSPITAL CARE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); OBESITY; PANDEMIC; PHASE 1 CLINICAL TRIAL (TOPIC); PHYSICAL ACTIVITY; PREVENTION AND CONTROL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SALT INTAKE; SEDENTARY LIFESTYLE; SMOKING; SOCIOECONOMICS; CARDIOVASCULAR DISEASES; ECONOMICS;

CARDIOVASCULAR DISEASES; CHINA; HUMANS; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84974851794     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.008728     Document Type: Article

References (184)

1. National Bureau of Statistics of People?s Republic of China. 2014 statistical bulletin of national economic and social development. http://www. stats.gov.cn/tjsj/tjgb/ndtjgb/index.html. Accessed July 20, 2015
2. China?s GDP in 1949-2011. http://www.360doc.com/content/12/1112/18/4375009-247444369.shtml. Accessed July 20, 2015
3. United Nations. Goal3: Ensure healthy lives and promote well-being for all at all ages. https://sustainabledevelopment.un.org/sdg3. Accessed December 22, 2015
4. Bulletin of the Third Plenary Session of the Eleventh Central Committee of the Communist Party of China. Beijing. December 22, 1978. http://news.xinhuanet.com/ziliao/2005-02/05/content-2550304.htm. Accessed May 25, 2016
5. National Bureau of Statistics of People?s Republic of China. China life expectancy. http://data.stats.gov.cn/easyquery.htm?cn=C01& zb=A0304& sj=2014. Accessed July 20, 2015
6. Institute of Health Metrics and Evaluation. Life expectancy globally and in China, 1990-2013. http://www.healthdata.org/china. Accessed January 20, 2016
7. National Health and Family Planning Commission of People?s Republic of China. Statistical bulletin on the development of health and family planning in 2013. http://www.nhfpc.gov.cn/guihuaxxs/s10742/201405/886f82 dafa344c3097f1d16581a1bea2.shtml. Accessed July 20, 2015
8. China population 2015. http://worldpopulationreview.com/countries/china-population. Accessed July 20, 2015
9. United Nations, Department of Economic and Social Affairs, Population Division. World Population Ageing 2013. ST/ESA/SER.A/348. Available at: http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf. Accessed April 20, 2016
10. Gong P, Liang S, Carlton EJ, Jiang Q, Wu J, Wang L, Remais JV. Urbanisation and health in China. Lancet. 2012; 379: 843-852. doi: 10.1016/S0140-6736(11)61878-3
11. Ministry of Environmental Protection of the People?s Republic of China. The China Environment Status Report 2012. http://www.zhb.gov.cn/gkml/hbb/qt/201306/t20130604-253201.htm. Accessed July 20, 2015
12. Oke O, Bhallac K, Loved DC, Siddiquia S. Tracking global bicycle ownership patterns. J Transport Health. 2015; 2: 490-501
13. Bell AC, Ge K, Popkin BM. The road to obesity or the path to prevention: motorized transportation and obesity in China. Obes Res. 2002; 10: 277-283. doi: 10.1038/oby.2002.38
14. Xie G, Mai J, Zhao L, Liu X, Zhou B, Li Y, Wu Y. Physical activity status of working time and its change over a ten-year period in Beijing and Guangzhou populations [in Chinese]. J. Hyg. Res. 2008; 37: 33-36
15. Ng SW, Howard AG, Wang HJ, Su C, Zhang B. The physical activity transition among adults in China: 1991-2011. Obes Rev. 2014; 15(suppl 1): 27-36. doi: 10.1111/obr.12127
16. National Center for Cardiovascular Diseases. Report on cardiovascular diseases in China. Beijing, China: Encyclopedia of China Publishing House; 2007
17. National Health and Family Planning Commission of People?s Republic of China. Report on status of nutrition and chronic diseases in China (2015). http://www.nhfpc.gov.cn/xcs/s3574/201506/6b4c0f873c174ace9f 57f11fd4f6f8d9.shtml. Accessed July 20, 2015.
18. Fan M, Lyu J, Guo Y, Bian Z, Yu C, Du H, Zhou H, Tan Y, Chen J, Chen Z, Li L. Regional differences on patterns of physical activity and leisure sedentary time: findings from the China Kadoorie Biobank study, including a million people from 10 regions [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2015; 36: 779-785
19. Ng SW, Norton EC, Popkin BM. Why have physical activity levels declined among Chinese adults? Findings from the 1991-2006 China Health and Nutrition Surveys. Soc Sci Med. 2009; 68: 1305-1314. doi: 10.1016/j.socscimed.2009.01.035
20. Zhang X, Xie, G, Zhang L, Li X, Zhao L, Li Y, Zhou B, Wu Y. Study on the baseline physical activity and the risk of ischemic cardiovascular disease. Chin J Epidemiol. 2006; 27: 930-933
21. Zhang J, Chaaban J. The economic cost of physical inactivity in China. Prev Med. 2013; 56: 75-78. doi: 10.1016/j.ypmed.2012.11.010
22. Ministry of Health, Ministry of Science and Technology and National Bureau of Statistics of People?s Republic of China. The nutrition and health status of Chinese residents. Chinese J Cardiovasc Rev. 2004; 2: 919-921
23. Dong F, Fuller F. Changing Diets in China?s Cities: Empirical Fact or Urban Legend? Working Paper 06-WP 437(2007), Ames, Iowa: Center for Agricultural and Rural Development Iowa State University. http://www.card.iastate.edu/iowa-ag-review/winter-07/article2.aspx. Accessed January 18, 2016
24. Zhai F, Du S, Wang Z, Zhang J, Du W, Popkin BM. Dynamics of the Chinese diet and the role of urbanicity, 1991 to 2011. Obes Rev. 2014; 15(suppl S1): 16-26
25. Zhao L, Hu J, Zheng R, Tian X, Ren F, Wu Y. The trend of dietary cholesterol intake and its food sources among workers and farmers in Beijing. Acta Nutrimenta Sinica. 2009; 31: 556-559
26. Dennis B, Zhou B, Liu X, Yang J, Mai J, Cao T, Ni G, Zhao L. Trends in food, nutrient and energy intake in People?s Republic of China samples of urban and rural north and south adults surveyed in 1983-84 and resurveyed in 1987-88. Asia Pacific J Clin Nutr. 1997; 6: 277-286
27. Anand SS, Hawkes C, de Souza RJ, Mente A, Dehghan M, Nugent R, Zulyniak MA, Weis T, Bernstein AM, Krauss RM, Kromhout D, Jenkins DJ, Malik V, Martinez-Gonzalez MA, Mozaffarian D, Yusuf S, Willett WC, Popkin BM. Food consumption and its impact on cardiovascular disease: importance of solutions focused on the globalized food system: a report from the workshop convened by the World Heart Federation. J Am Coll Cardiol. 2015; 66: 1590-1614. doi: 10.1016/j.jacc.2015.07.050
28. Du H, Li L, Bennett D, Guo Y, Key TJ, Bian Z, Sherliker P, Gao H, Chen Y, Yang L, Chen J, Wang S, Du R, Su H, Collins R, Peto R, Chen Z; China Kadoorie Biobank Study. Fresh fruit consumption and major cardiovascular disease in China. N Engl J Med. 2016; 374: 1332-1343. doi: 10.1056/NEJMoa1501451
29. Lv J, Qi L, Yu C, Yang L, Guo Y, Chen Y, Bian Z, Sun D, Du J, Ge P, Tang Z, Hou W, Li Y, Chen J, Chen Z, Li L; China Kadoorie Biobank Collaborative Group. Consumption of spicy foods and total and cause specific mortality: population based cohort study. BMJ. 2015; 351: h3942
30. China Industry Information. Beverage production in China in 2014. http://www.chyxx.com/industry/201508/333270.html. Accessed January 18, 2016
31. Li D. Current status and trend in food and beverages containing added sugar in adults from 9 provinces in China, from 1997 to 2009. Beijing: China Center for Disease Control and Prevention; 2014: R151.41
32. Ding C, Guo H, Song C, Liu A. A meta-Analysis of relationship between consumption of sugar-contained beverages and obesity and body weight change. Zhong Guo Man Xing Bing Yu Fang Yu Kong Zhi Za Zhi. 2015; 7: 506-511
33. Zhou Y, Du S, Su C, Zhang B, Wang H, Popkin BM. The food retail revolution in China and its association with diet and health. Food Policy. 2015; 55: 92-100. doi: 10.1016/j.foodpol.2015.07.001
34. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ.1988; 297: 319-328
35. Stamler R, Liu LS, Nichols R, Huang DX, Long ZP, Xie JX, Elliott P. Blood pressure and life style in the People?s Republic of China: three samples in the INTERSALT Study. J Hum Hypertens. 1993; 7: 429-435
36. World Health Organization. Reducing salt intake in populations: report of a WHO forum and technical meeting, 5-7 October 2006, Paris, France. www.who.int/dietphysicalactivity/SaltReport-VC-April07. Accessed January 18, 2016
37. Yan L, Li N, Wu Y. Salt restriction and challenges in china for hypertension control. Curr Cardiovasc Risk Rep. 2011; 5: 180-186
38. Yan L, Li Y, Wu Y. Reducing salt intake for hypertension control: related evidence and recommendation on strategies in China. Chin J Epidemiol. 2011; 32: 1188-1192
39. Liu LS, Tao SC, Lai SH. Relationship between salt excretion and blood pressure in various regions of China. Bull World Health Organ. 1984; 62: 255-260
40. Zhou BF, Wu XG, Tao SQ, Yang J, Cao TX, Zheng RP, Tian XZ, Lu CQ, Miao HY, Ye FM. Dietary patterns in 10 groups and the relationship with blood pressure. Collaborative Study Group for Cardiovascular Diseases and Their Risk Factors. Chin Med J (Engl). 1989; 102: 257-261
41. Zhao L, Zhou B, Yang J, Zhang H, Wu Y. Association of food intake with blood pressure among different population. Chin J Prev Contr Chron Noneommun Dis. 1996; 4: 155-159
42. Liu L, Liu L, Ding Y, Huang Z, He B, Sun S, Zhao G, Zhang H, Miki T, Mizushima S, Ikeda K, Nara Y, Yamori Y. Ethnic and environmental differences in various markers of dietary intake and blood pressure among Chinese Han and three other minority peoples of China: results from the WHO Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study. Hypertens Res. 2001; 24: 315-322
43. Xie J, Hao J, Liu L. Relationship between urinary electrolytes and blood pressure in 16 regions of China. Chin J Hyperten. 2002; 10: 172-175
44. Zhou B, Zhang X, Zhu A, Zhao L, Zhu S, Ruan L, Zhu L, Liang S. The relationship of dietary animal protein and electrolytes to blood pressure: a study on three Chinese populations. Int J Epidemiol. 1994; 23: 716-722
45. Tian HG, Nan Y, Shao RC, Dong QN, Hu G, Pietinen P, Nissinen A. Associations between blood pressure and dietary intake and urinary excretion of electrolytes in a Chinese population. J Hypertens. 1995; 13: 49-56
46. Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, Zhao L, Chan Q, Elliott P; INTERMAP Research Group. Nutrient intakes of middle-Aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens. 2003; 17: 623-630. doi: 10.1038/sj.jhh.1001605
47. Zhao L, Stamler J, Yan LL, Zhou B, Wu Y, Liu K, Daviglus ML, Dennis BH, Elliott P, Ueshima H, Yang J, Zhu L, Guo D; INTERMAP Research Group. Blood pressure differences between northern and southern Chinese: role of dietary factors: the International Study on Macronutrients and Blood Pressure. Hypertension. 2004; 43: 1332-1337. doi: 10.1161/01.HYP.0000128243.06502.bc
48. Ma G, Zhou Q, Hu X. Relationship between salt consumption and hypertension in Chinese people. Chin J Prev Contr Chron Non-commun Dis. 2008; 16: 441-444
49. Klag MJ, He J, Coresh J, Whelton PK, Chen JY, Mo JP, Qian MC, Mo PS, He GQ. The contribution of urinary cations to the blood pressure differences associated with migration. Am J Epidemiol. 1995; 142: 295-303
50. Wu Y, Cai R, Zhou B, Xu X. Effects of genetic factors and dietary electrolytes on blood pressure of rural secondary school students in Hanzhong. Chin Med Sci J. 1991; 6: 148-152
51. Batis C, Gordon-Larsen P, Cole SR, Du S, Zhang B, Popkin B. Sodium intake and incident hypertension among Chinese adults: estimated effects across three different exposure periods. Epidemiology. 2013; 24: 410-418. doi: 10.1097/EDE.0b013e318289e047
52. Du S, Neiman A, Batis C, Wang H, Zhang B, Zhang J, Popkin BM. Understanding the patterns and trends of sodium intake, potassium intake, and sodium to potassium ratio and their effect on hypertension in China. Am J Clin Nutr. 2014; 99: 334-343. doi: 10.3945/ajcn.113.059121
53. Yan L, Bi Z, Tang J, Wang L, Yang Q, Guo X, Cogswell ME, Zhang X, Hong Y, Engelgau M, Zhang J, Elliott P, Angell SY, Ma J. Relationships between blood pressure and 24-hour urinary excretion of sodium and potassium by body mass index status in Chinese adults. J Clin Hypertens (Greenwich). 2015; 17: 916-925. doi: 10.1111/jch.12658
54. Wu Y, Wu X, Zhou B. Salt reduction in 16 farmer families and its effect on blood pressure. Chin Circulation J. 1994; 9: 347-349
55. Wu X, Cao T, Zhu Y. Effects of dietary pattern modification on blood pressure over in a work site intervention program. Chin J Cardiol.1999; 27: 22-25
56. He FJ, Wu Y, Feng XX, Ma J, Ma Y, Wang H, Zhang J, Yuan J, Lin CP, Nowson C, MacGregor GA. School based education programme to reduce salt intake in children and their families (School-EduSalt): cluster randomised controlled trial. BMJ. 2015; 350: h770.
57. China Salt Substitute Study Collaborative Group. Salt substitution: a lowcost strategy for blood pressure control among rural Chinese. A randomized, controlled trial. J Hyperten. 2007; 25: 2011-2018
58. Zhao X, Yin X, Li X, Yan LL, Lam CT, Li S, He F, Xie W, Sang B, Luobu G, Ke L, Wu Y. Using a low-sodium, high-potassium salt substitute to reduce blood pressure among Tibetans with high blood pressure: a patient-blinded randomized controlled trial. PLoS One. 2014; 9: e110131. doi: 10.1371/journal.pone.0110131
59. Zhou B, Wang HL, Wang WL, Wu XM, Fu LY, Shi JP. Long-Term effects of salt substitution on blood pressure in a rural north Chinese population. J Hum Hypertens. 2013; 27: 427-433. doi: 10.1038/jhh.2012.63
60. Cochrane J, Chen H, Conigrave KM, Hao W. Alcohol use in China. Alcohol. 2003; 38: 537-542
61. Tang YL, Xiang XJ, Wang XY, Cubells JF, Babor TF, Hao W. Alcohol and alcohol-related harm in China: policy changes needed. Bull World Health Organ. 2013; 91: 270-276. doi: 10.2471/BLT.12.107318
62. Hao W, Chen H, Su Z. China: alcohol today. Addiction. 2005; 100: 737-741. doi: 10.1111/j.1360-0443.2005.01036.x
63. Li Y, Jiang Y, Zhang M, Yin P, Wu F, Zhao W. Drinking behaviour among men and women in China: the 2007 China Chronic Disease and Risk Factor Surveillance. Addiction. 2011; 106: 1946-1956. doi: 10.1111/j.1360-0443.2011.03514.x
64. Bazzano LA, Gu D, Reynolds K, Chen J, Wu X, Chen CS, Duan X, Chen J, He J. Alcohol consumption and risk of coronary heart disease among Chinese men. Int J Cardiol. 2009; 135: 78-85. doi: 10.1016/j.ijcard.2008.03.038
65. Zhang L, Zhao L, Zhou B, Yang J, Li Y, Wu Y. Alcohol consumption and incidence of ischemic stroke in male Chinese. Chin J Epidemiol. 2004; 25: 954-957
66. Li Q, Hsia J, Yang G. Prevalence of smoking in China in 2010. N Engl J Med. 2011; 364: 2469-2470. doi: 10.1056/NEJMc1102459
67. Xiao L, Yang Y, Li Q, Wang CX, Yang GH. Population-based survey of secondhand smoke exposure in China. Biomed Environ Sci. 2010; 23: 430-436. doi: 10.1016/S0895-3988(11)60003-2
68. Dunbar A, Gotsis W, Frishman W. Second-hand tobacco smoke and cardiovascular disease risk: an epidemiological review. Cardiol Rev. 2013; 21: 94-100. doi: 10.1097/CRD.0b013e31827362e4
69. He Y, Lam TH, Jiang B, Wang J, Sai X, Fan L, Li X, Qin Y, Hu FB. Passive smoking and risk of peripheral arterial disease and ischemic stroke in Chinese women who never smoked. Circulation. 2008; 118: 1535-1540. doi: 10.1161/CIRCULATIONAHA.108.784801
70. The CPC Central Committee and the General Office of the State Council. The circular on the leading cadres to take the lead in public places to ban smoking in public places. Beijing: December 2013
71. China intends to legislate all indoor public places no smoking. China News. November 24, 2014. Available at: http://www.chinanews.com/gn/2014/11-24/6809399.shtml. Accessed January 18, 2016
72. The Standing Committee of the Fourteenth Beijing Municipal People?s Congress. The Beijing municipal control smoking regulation. Adopted November 28, 2014; officially implemented June 1, 2015
73. 2015 China Adult Tobacco Survey Report. Beijing: China Center for Disease Control and Prevention; December 28, 2015
74. Hu TW, Zhang X, Zheng R. China has raised the tax on cigarettes: what?s next? Tob Control. 2015; 0: 1-3
75. Meyers DG, Neuberger JS, He J. Cardiovascular effect of bans on smoking in public places: a systematic review and meta-Analysis. J Am Coll Cardiol. 2009; 54: 1249-1255. doi: 10.1016/j.jacc.2009.07.022
76. Gulland A. Countries should raise taxes on tobacco, says WHO. BMJ. 2015; 351: h3691
77. National Technical Supervision Bureau. People?s Republic of China Groundwater Quality Standard (GB/T 14848-93). Issued December 30, 1993; implemented October 1, 1994
78. Ministry of Environment Protection and National Technical Supervision Bureau. People?s Republic of China Ambient air quality standards (GB 3095-2012). Issued Feburary 29, 2012; implemented January 1, 2016
79. World Health Organization. Air Quality Guidelines. Global Update 2005.Particulate Matter, Ozone, Nitrogen Dioxide and Sulfur Dioxide. http://www.euro.who.int/en/health-Topics/environment-And-health/Housingand-health/publications/pre-2009/air-quality-guidelines.-global-update-2005.-particulate-matter,-ozone,-nitrogen-dioxide-And-sulfur-dioxide. Accessed January 18, 2016
80. US Environmental Protection Agency. National Ambient Air Quality Standards (NAAQS). http://www3.epa.gov/ttn/naaqs/. Accessed January 18, 2016
81. Ministry of Environmental Protection of the People?s Republic of China. Soil Pollution in China. http://sts.mep.gov.cn/trhjbh/qgtrxzdc/200607/t20060720-91677.htm. Accessed July 20, 2015
82. Kan H, Huang W, Chen B, Zhao N. Impact of outdoor air pollution on cardiovascular health in Mainland China. CVD Prevent Control. 2009; 4: 71-78
83. Xu M, Guo Y, Zhang Y, Westerdahl D, Mo Y, Liang F, Pan X. Spatiotemporal analysis of particulate air pollution and ischemic heart disease mortality in Beijing, China. Environ Health. 2014; 13: 109. doi: 10.1186/1476-069X-13-109
84. Li G, Zhou M, Zhang Y, Cai Y, Pan X. Seasonal effects of PM10 concentrations on mortality in Tianjin, China: a time-series analysis. J Public Health. 2013; 21: 135-144
85. Chen R, Samoli E, Wong CM, Huang W, Wang Z, Chen B, Kan H; CAPES Collaborative Group. Associations between short-Term exposure to nitrogen dioxide and mortality in 17 Chinese cities: the China Air Pollution and Health Effects Study (CAPES). Environ Int. 2012; 45: 32-38. doi: 10.1016/j.envint.2012.04.008
86. Zhang A, Qi Q, Jiang L, Zhou F, Wang J. Population exposure to PM2.5 in the urban area of Beijing. PLoS One. 2013; 8: e63486. doi: 10.1371/journal.pone.0063486
87. Xie W, Li G, Zhao D, Xie X, Wei Z, Wang W, Wang M, Li G, Liu W, Sun J, Jia Z, Zhang Q, Liu J. Relationship between fine particulate air pollution and ischaemic heart disease morbidity and mortality. Heart. 2015; 101: 257-263. doi: 10.1136/heartjnl-2014-306165
88. National Research Council (US) Subcommittee on Arsenic in Drinking Water. Arsenic in Drinking Water. Washington, DC: National Academies Press; 1999
89. Chen R, Zhao A, Chen H, Zhao Z, Cai J, Wang C, Yang C, Li H, Xu X, Ha S, Li T, Kan H. Cardiopulmonary benefits of reducing indoor particles of outdoor origin: a randomized, double-blind crossover trial of air purifiers. J Am Coll Cardiol. 2015; 65: 2279-2287. doi: 10.1016/j. jacc.2015.03.553
90. Pope CA 3rd, Dockery DW. Health effects of fine particulate air pollution: lines that connect. J Air Waste Manag Assoc. 2006; 56: 709-742
91. Huang C, Yu H, Koplan JP. Can China diminish its burden of noncommunicable diseases and injuries by promoting health in its policies, practices, and incentives? Lancet. 2014; 384: 783-792. doi: 10.1016/S0140-6736(14)61214-9
92. Saikawa E, Naik V, Horowitz L, Liu J, Mauzerall D. Present and potential future contributions of sulfate, black and organic carbon aerosols from China to global air quality, premature mortality and, radiative forcing. Atmospheric Environ. 2009; 43: 2814-2822
93. Zhang J, Mauzerall DL, Zhu T, Liang S, Ezzati M, Remais JV. Environmental health in China: progress towards clean air and safe water. Lancet. 2010; 375: 1110-1119. doi: 10.1016/S0140-6736(10)60062-1
94. Cohen AJ, Ross Anderson H, Ostro B, Pandey KD, Krzyzanowski M, Künzli N, Gutschmidt K, Pope A, Romieu I, Samet JM, Smith K. The global burden of disease due to outdoor air pollution. J Toxicol Environ Health A. 2005; 68: 1301-1307. doi: 10.1080/15287390590936166
95. Wang X, Mauzerall D. Evaluating impacts of air pollution in China on public health: implications for future air pollution and energy policies. Atmospheric Environ. 2006; 40: 1706-1721
96. National Blood Pressure Survey Cooperative Group. Prevalence and development of hypertension in China. Chin J Hypertens. 1995; 3(suppl): 7-13
97. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, Woodward M, Li X, Chalmers J, Gao R, Kong L, Yang X; China NNHS Steering Committee; China NNHS Working Group. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008; 118: 2679-2686. doi: 10.1161/CIRCULATIONAHA.108.788166
98. Wu X, Wu Y, Zhou B, Tao S, Shen L, Wang S, Zhu S, Xu X, Yang R, Du F, Wang Y, He H, Xia S, Ruan L. The incidence of hypertension and associated factors in 10 population groups of China. Natl Med J China. 1996; 76: 24-29
99. Hu B, Liu X, Yin S, Fan H, Feng F, Yuan J. Effects of psychological stress on hypertension in middle-Aged Chinese: a cross-sectional study. PLoS One. 2015; 10: e0129163. doi: 10.1371/journal.pone.0129163
100. Greenstadt L, Yang L, Shapiro D. Caffeine, mental stress, and risk for hypertension: a cross-cultural replication. Psychosom Med. 1988; 50: 15-22
101. Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu S, Li Y, Wang L, Liu Y, Yin P, Liu J, Yu S, Tan F, Barber RM, Coates MM, Dicker D, Fraser M, González-Medina D, Hamavid H, Hao Y, Hu G, Jiang G, Kan H, Lopez AD, Phillips MR, She J, Vos T, Wan X, Xu G, Yan LL, Yu C, Zhao Y, Zheng Y, Zou X, Naghavi M, Wang Y, Murray CJ, Yang G, Liang X. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016; 387: 251-272. doi: 10.1016/S0140-6736(15)00551-6
102. Wong LD, eds. The 2002 China National Nutrition and Health Survey (1): General Report. Beijing: People Health Publishing House; 2005
103. Yang W, Xiao J, Yang Z, Ji L, Jia W, Weng J, Lu J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J; China National Diabetes and Metabolic Disorders Study Investigators. Serum lipids and lipoproteins in Chinese men and women. Circulation. 2012; 125: 2212-2221. doi: 10.1161/CIRCULATIONAHA.111.065904
104. The Collaborative Study Group on Trends of Cardiovascular Disease in China and Preventive Strategy. Current status of major cardiovascular risk factors in Chinese populations and their trends in the past two decades. Chin J Cardiol. 2001; 29: 74-79
105. National Diabetes Research Group. A mass survey of diabetes mellitus in a population of 300, 000 in 14 provinces and municipalities in China. Zhonghua Nei Ke Za Zhi. 1981; 20: 678-683
106. Pan XR, Yang WY, Li GW, Liu J. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care. 1997; 20: 1664-1669
107. Gu D, Reynolds K, Duan X, Xin X, Wu X, Mo J, Whelton P, He J. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population. Diabetologia. 2003; 46: 1190-1198
108. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J; China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362: 1090-1101. doi: 10.1056/NEJMoa0908292
109. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G; 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults. JAMA. 2013; 310: 948-959. doi: 10.1001/jama.2013.168118
110. Wu Y. Overweight and obesity in China. BMJ. 2006; 333: 362-363. doi: 10.1136/bmj.333.7564.362
111. Obesity: a growing threat to health in China. Lancet. 2014; 384: 716
112. Department of Disease Control Ministry of Health, PR China. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004; 17(suppl): 1-36
113. World Health Organization. Obesity and overweight. http://www.who. int/mediacentre/factsheets/fs311/en/. Accessed January 18, 2016
114. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, Abraham JP, Abu-Rmeileh NM, Achoki T, AlBuhairan FS, Alemu ZA, Alfonso R, Ali MK, Ali R, Guzman NA, Ammar W, Anwari P, Banerjee A, Barquera S, Basu S, Bennett DA, Bhutta Z, Blore J, Cabral N, Nonato IC, Chang JC, Chowdhury R, Courville KJ, Criqui MH, Cundiff DK, Dabhadkar KC, Dandona L, Davis A, Dayama A, Dharmaratne SD, Ding EL, Durrani AM, Esteghamati A, Farzadfar F, Fay DF, Feigin VL, Flaxman A, Forouzanfar MH, Goto A, Green MA, Gupta R, Hafezi-Nejad N, Hankey GJ, Harewood HC, Havmoeller R, Hay S, Hernandez L. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384: 766-781. doi: 10.1016/S0140-6736(14)60460-8
115. Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, Zhao LC, Huang YN, Chen J, Wu YF; Collaborative Group of China Multicenter Study of Cardiovascular Epidemiology. Proportion of different subtypes of stroke in China. Stroke. 2003; 34: 2091-2096. doi: 10.1161/01.STR.0000087149.42294.8C
116. WHO Department of Measurement and Health Information. Disease and Injury Country Estimates. http://www.who.int/healthinfo/global-burden-disease/estimates-country/en. Accessed July 20, 2015
117. World Bank. Toward a healthy and harmonious life in China: Stemming the rising tide of non-communicable diseases. World Bank Report Number 62318-cn. http://documents.worldbank.org/curated/en/2011/07/14639951/toward-healthy-harmonious-life-china-stemmingrising-Tide-non-communicable-diseases. Accessed July 20, 2015
118. Yu D. Analysis on health costs in China. Chin Health Econ Mag. 2005; 24: 5-7
119. Hu D. Thinking on the prevention, treatment and patient rehabilitation of cardiovascular disease in China. Chin J Pract Intern Med. 2013; 33: 253-255
120. National Bureau of Statistics of People?s Republic of China. Health cost in China. http://data.stats.gov.cn/easyquery.htm?cn=C01& zb=A0O0K& sj=2014. Accessed July 20, 2015
121. National Bureau of Statistics of People?s Republic of China. Private expenditure on health care. http://data.stats.gov.cn/adv.htm?m=advquery& cn=C01. Accessed July 20, 2015
122. Heeley E, Anderson CS, Huang Y, Jan S, Li Y, Liu M, Sun J, Xu E, Wu Y, Yang Q, Zhang J, Zhang S, Wang J; ChinaQUEST Investigators. Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke. 2009; 40: 2149-2156. doi: 10.1161/STROKEAHA.108.540054
123. World Bank. GDP per capita (current US$). http://data.worldbank. org/indicator/NY.GDP.PCAP.CD?display=default. Accessed July 20, 2015
124. Baidu baike. China?s standard of poverty. http://baike.baidu.com/lin k?url=gYWmIr9wjvy7pd3Gxmq548m9FQhMa-Br50U9chDhL3FsOulfmAoYynTlCAR4Wv6jG2-YpM5piIC4Kz52SoLMHK. Accessed January 18, 2016
125. World Bank. Poverty & Equity. http://povertydata.worldbank.org/poverty/country/CHN. Accessed July 20, 2015
126. Molarius A, Seidell JC, Sans S, Tuomilehto J, Kuulasmaa K. Educational level, relative body weight, and changes in their association over 10 years: an international perspective from the WHO MONICA Project. Am J Public Health. 2000; 90: 1260-1268
127. Yu Z, Nissinen A, Vartiainen E, Song G, Guo Z, Tian H. Changes in cardiovascular risk factors in different socioeconomic groups: seven year trends in a Chinese urban population. J Epidemiol Community Health. 2000; 54: 692-696
128. Yu Z, Nissinen A, Vartiainen E, Song G, Guo Z, Zheng G, Tuomilehto J, Tian H. Associations between socioeconomic status and cardiovascular risk factors in an urban population in China. Bull World Health Organ. 2000; 78: 1296-1305
129. Gao B, Zhang L, Wang H; the China National Survey of Chronic Kidney Disease Working Group. Clustering of major cardiovascular risk factors and the association with unhealthy lifestyles in the Chinese adult population. PLoS One. 2013; 8: e66780. doi: 10.1371/journal. pone.0066780
130. Zhan Y, Yu J, Chen R, Gao J, Ding R, Fu Y, Zhang L, Hu D. Socioeconomic status and metabolic syndrome in the general population of China: a cross-sectional study. BMC Public Health. 2012; 12: 921. doi: 10.1186/1471-2458-12-921
131. Dou L, Liu X, Zhang T, Wu Y. Health care utilization in older people with cardiovascular disease in China. Int J Equity Health. 2015; 14: 59. doi: 10.1186/s12939-015-0190-y
132. Gao Y, Chen G, Tian H, Lin L, Lu J, Weng J, Jia W, Ji L, Xiao J, Zhou Z, Ran X, Ren Y, Chen T, Yang W; China National Diabetes and Metabolic Disorders Study Group. Prevalence of hypertension in china: a cross-sectional study. PLoS One. 2013; 8: e65938. doi: 10.1371/journal. pone.0065938
133. Huang Y, Gao L, Xie X, Tan SC. Epidemiology of dyslipidemia in Chinese adults: meta-Analysis of prevalence, awareness, treatment, and control. Popul Health Metr. 2014; 12: 28. doi: 10.1186/s12963-014-0028-7
134. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010; 303: 2043-2050. doi: 10.1001/jama.2010.650
135. The US CDC. National Diabetes Statistics Report, 2014. http://www. cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed April 20, 2016
136. Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, Gupta R, Kelishadi R, Iqbal R, Avezum A, Kruger A, Kutty R, Lanas F, Lisheng L, Wei L, Lopez-Jaramillo P, Oguz A, Rahman O, Swidan H, Yusoff K, Zatonski W, Rosengren A, Teo KK; Prospective Urban Rural Epidemiology (PURE) Study Investigators. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011; 378: 1231-1243. doi: 10.1016/S0140-6736(11)61215-4
137. Blumenthal D, Hsiao W. Privatization and its discontents-The evolving Chinese health care system. N Engl J Med. 2005; 353: 1165-1170. doi: 10.1056/NEJMhpr051133
138. Hsiao WC. Disparity in health: the underbelly of China?s economic development. Harv China Rev. 2004; 5: 64-70
139. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994; 90: 583-612
140. Gao R, Patel A, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Harris P, Algert C, Groenestein P, Turnbull F; CPACS Investigators. Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart. 2008; 94: 554-560. doi: 10.1136/hrt.2007.119750
141. Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F; CPACS Investigators. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart J. 2009; 157: 509-516.e1. doi: 10.1016/j.ahj.2008.09.026
142. Guo L, Wang J, Zhao D, Liu J, Liu J, Zhang H, Xing L, Sun J, Wang M. Current clinical practice and guideline application in therapies of ST segment elevation ACS inpatient in a multi-provincial study in China: results of BRIG project. Heart. 2010; 96(suppl 3): A81-A82
143. The Collaborative Research Group for the Second Multi-center Survey of Clinical Management of Dyslipidemia in China. The second multicenter survey of dyslipidemia management in China: goal attainment rate and related factors. Chin J Cardiol. 2007; 35: 420-427
144. The coronry stent market in China. http://news.39.net/mtpl/2012222/1978515.html. Accessed July 20, 2015
145. Li J, Li X, Wang Q, Hu S, Wang Y, Masoudi FA, Spertus JA, Krumholz HM, Jiang L; China PEACE Collaborative Group. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet. 2015; 385: 441-451. doi: 10.1016/S0140-6736(14)60921-1
146. Li M, Wu Y, eds. Urbanization and Health in China. London: Imperial College Press; 2015
147. The Lancet. Violence against doctors: Why China? Why now? What next? Lancet. 2014; 383(9922), p1013
148. Livelihood become major political issues of National People?s Congress and Chinese People?s Political Consultative Conference, Chinese people?s livelihood political speed up. http://www.chinanews. com/gn/2011/03-10/2897757.shtml. Accessed July 20, 2015
149. People?s livelihood is the biggest politics. http://news.gmw.cn/2014-03/07/content-10603378.htm. Accessed July 20, 2015
150. CPC Central Committee and the State Council. Decision on health reform and development (January 15, 1997). http://www.moh.gov.cn/wsb/pM30115/200804/18540.shtml. Accessed July 20, 2015
151. CPC Central Committee and the State Council. Decision on further strengthening the work of rural health (October 19, 2002). http://www. gov.cn/gongbao/content/2002/content-61818.htm. Accessed July 20, 2015
152. National Health and Family Planning Commission of People?s Republic of China. Notice on the work of the national basic public health service project in 2014. http://www.nhfpc.gov.cn/jws/s3577/201409/acaeab089ac44d7a87d38393ccec4a78. shtml. Accessed July 20, 2015
153. China Food and Drug Administration. Notice on printing and distribution of The Implementation Guidance on the Establishment of the National Essential Drug List System. http://www.sda.gov.cn/WS01/CL0056/40753.html. Accessed July 20, 2015
154. Zhou D, Feng Z, He S, Sun X, Ma C, Lv B, Zou X. Equity of the essential public health service in rural china: evidence from a nationwide survey of hypertensive patients. Pak J Med Sci. 2013; 29: 1012-1017
155. Tian M, Wang H, Tong X, Zhu K, Zhang X, Chen X. Essential public health services? accessibility and its determinants among adults with chronic diseases in China. PLoS One. 2015; 10: e0125262. doi: 10.1371/journal.pone.0125262
156. Barber S, Huang B, Santoso B, Laing R, Paris V, Wu C. The reform of the essential medicines system in China: a comprehensive approach to universal coverage. Viewpoints. 2013; 3: 1-9
157. Yu Q, Liu Y, Li X, Deng B. The effects of implementing National Essential Drugs System in primary care facilities in Zhongshan. China Pharmaceuticals. 2011; 12: 2-3
158. Yip WC, Hsiao WC, Chen W, Hu S, Ma J, Maynard A. Early appraisal of China?s huge and complex health-care reforms. Lancet. 2012; 379: 833-842. doi: 10.1016/S0140-6736(11)61880-1
159. Fang Y, Wagner AK, Yang S, Jiang M, Zhang F, Ross-Degnan D. Access to affordable medicines after health reform: evidence from two crosssectional surveys in Shaanxi Province, western China. Lancet Glob Health. 2013; 1: e227-e237. doi: 10.1016/S2214-109X(13)70072-X
160. Yao Q, Luo F, He L, Chen S, Yao L, Liu Z. Effectiveness evaluation of national essential medicine system in China from the perspective of drug access. Chin Hosp Manag. 2014; 34: 60-62
161. Chen Y, Xin Y. Effect of essential drug distribution on the security of drug supply in China. Shanghai Med Pharmaceut J. 2015; 35: 66-72
162. Liang N, Chen Z, Zeng L, Liang Z, Wu H. Adverse drug reactions/adverse drug events induced by national essential drugs: analysis of 12 198 cases. Evaluation and Analysis of Drug-Use in Hospitals of China 2013; 13: 64-66
163. The Ministry of Health General Office. Circular on the conduct of the National Action on Healthy Lifestyle for All. Document No.: [2007]189. http://www.nhfpc.gov.cn/mohbgt/pw10801/200804/19287.shtml. Accessed July 20, 2015
164. The summary of the work in National Action on Healthy Lifestyle for All in 2014. http://www.docin.com/p-1217956143.html. Accessed July 20, 2015
165. The State Council. National Plan on Public Exercise: Healthy Body for All. http://www.china.com.cn/chinese/zhuanti/tyzcfg/885961.htm. Accessed July 20, 2015
166. United Nations General Assembly Sixty-sixth Session. Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases (A/RES/66/2). Geneva, Switzerland: January 24, 2012
167. Ministry of Health and other 14 ministries. Notice of the issuance of the work plan for the prevention and control of chronic diseases in China (2012-2015). 2012
168. State Council. Air pollution control action plan. Released on September 10, 2013
169. People?s Republic of China Environment Protection Law. Issued April 25, 2014; implemented since January 1, 2015
170. Cheney J. Speech at the 2016 National Conference on Environment Protection. January 11, 2016. http://www.mep.gov.cn/gkml/hbb/qt/201601/t20160114-326153.htm. Accessed January 18, 2016
171. Policy of prevention in the first place and integrating prevention with control. http://www.people.com.cn/electric/hh50/9/9-3-2.html. Accessed July 20, 2015
172. National Health and Family Planning Commission of People?s Republic of China. Age-specific expected life years. http://www.moh.gov.cn/open/2007tjts/P65.htm. Accessed July 20, 2015
173. National Bureau of Statistics of People?s Republic of China. China average per capita GDP. http://data.stats.gov.cn/easyquery.htm?cn=C01& zb=A0A03& sj=2014. Accessed July 20, 2015
174. World Health Organization, World Economic Forum. From Burden to Best Buys: Reducing the Economic Impact of Non-Communicable Diseases in Low-And Middle-Income Countries. Geneva, Switzerland: September 18, 2011
175. CPC Central Committee and the State Council. Opinions on deepening the reform of the medical and health system. Issued on March 17, 2009. http://www.gov.cn/test/2009-04/08/content-1280069.htm. Accessed July 20, 2015
176. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, Baugh V, Bekedam H, Billo N, Casswell S, Cecchini M, Colagiuri R, Colagiuri S, Collins T, Ebrahim S, Engelgau M, Galea G, Gaziano T, Geneau R, Haines A, Hospedales J, Jha P, Keeling A, Leeder S, Lincoln P, McKee M, Mackay J, Magnusson R, Moodie R, Mwatsama M, Nishtar S, Norrving B, Patterson D, Piot P, Ralston J, Rani M, Reddy KS, Sassi F, Sheron N, Stuckler D, Suh I, Torode J, Varghese C, Watt J; Lancet NCD Action Group; NCD Alliance. Priority actions for the non-communicable disease crisis. Lancet. 2011; 377: 1438-1447. doi: 10.1016/S0140-6736(11)60393-0
177. Advisory Board of the International Heart Health Conference. Victoria declaration on heart health. CMAJ. 1992; 147: 1794-1797.172
178. Tian M, Ajay VS, Dunzhu D, Hameed SS, Li X, Liu Z, Li C, Chen H, Cho KW, Li R, Zhao X, Jindal D, Rawal I, Ali MK, Peterson ED, Ji J, Amarchand R, Krishnan A, Tandon N, Xu L, Wu Y, Prabhakaran D, Yan LL. A Cluster-Randomized, Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, India. Circulation. 2015; 132: 815-824
179. Yan LL, Fang W, Delong E, Neal B, Peterson ED, Huang Y, Sun N, Yao C, Li X, MacMahon S, Wu Y. Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial. BMC Public Health. 2014; 14: 345
180. Li N, Yan LL, Niu W, Labarthe D, Feng X, Shi J, Zhang J, Zhang R, Zhang Y, Chu H, Neiman A, Engelgau M, Elliott P, Wu Y, Neal B. A large-scale cluster randomized trial to determine the effects of community-based dietary sodium reduction-The China Rural Health Initiative Sodium Reduction Study. Am Heart J. 2013; 166: 815-822. doi: 10.1016/j. ahj.2013.07.009
181. Du X, Gao R, Turnbull F, Wu Y, Rong Y, Lo S, Billot L, Hao Z, Ranasinghe I, Iedema R, Kong L, Hu D, Lin S, Shen W, Huang D, Yang Y, Ge J, Han Y, Lv S, Ma A, Gao W, Patel A; CPACS Investigators. Hospital quality improvement initiative for patients with acute coronary syndromes in China: a cluster randomized, controlled trial. Circ Cardiovasc Qual Outcomes. 2014; 7: 217-226. doi: 10.1161/CIRCOUTCOMES.113.000526
182. Li S, Wu Y, Du X, Li X, Patel A, Peterson ED, Turnbull F, Lo S, Billot L, Laba T, Gao R. on behalf of the CPACS-3 investigators. Rational and design of a stepped-wedge cluster randomized trial evaluating quality improvement initiative for reducing cardiovascular events among patients with acute coronary syndromes in resource-constrained hospitals in China. Am Heart J. 2015; 169: 349-355
183. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH. The long-Term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008; 371: 1783-1789. doi: 10.1016/S0140-6736(08)60766-7
184. Yu R, Yan LL, Wang H, Ke L, Yang Z, Gong E, Guo H, Liu J, Gu Y, Wu Y. Effectiveness of a community-based individualized lifestyle intervention among older adults with diabetes and hypertension, Tianjin, China, 2008-2009. Prev Chronic Dis. 2014; 11: 120333